Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress

被引:1
|
作者
Adachi, Tatsuhiko [1 ]
Nakagawa, Hiroshi [1 ]
Chung, Ivy [1 ]
Hagiya, Yuichiro [1 ]
Hoshijima, Kazuyuki [1 ]
Noguchi, Noriko [2 ]
Kuo, Macus Tien [3 ]
Ishikawa, Toshihisa [1 ]
机构
[1] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, 4259-B-60 Nagatsuta Cho,4259-B-60 Nagatsuta, Yokohama, Kanagawa 2268501, Japan
[2] Univ Tokyo, Res Ctr Adv Sci & Technol LSBM, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan
[3] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nrf2, an NF-E2-related transcription factor, plays a critical role in transcriptional upregulation of many target genes, including those for metabolizing enzymes and transporters essential for cellular defense in response to oxidative and/or electrophilic stress. In the present study, we have studied the potential involvement of Nrf2 in induction of human ABC transporter genes under oxidative stress. We created a real-time PCR primer set to quantitatively investigate the induction of human ABC transporters by a redox-active compound tert-butylhydroquinone (tBHQ) in HepG2 cells. We found that mRNA levels of ABCC1, ABCC2, ABCC3, and ABCG2 were significantly elevated in dose-and time-dependent manners. Translocation of Nrf2 into the nuclei occurred concomitantly with the induction of ABCC1 and ABCC2 as well as both heavy and light chains of gamma-glutamylcysteine synthetase (gamma-GCSh and gamma-GCSl) during tBHQ treatments. To examine the potential involvement of Nrf2 in upregulation of the ABC transporters, we treated cells with siRNA to knockdown the expression of Nrf2. Under such Nrf2-knockdown conditions, tBHQ-induced mRNA levels of ABCC2 and ABCG2 were significantly suppressed as were mRNA levels of gamma-GCSh and gamma-GCSl. Interestingly, however, the elevated mRNA level of ABCC1 was little affected by Nrf2 siRNA treatment. We also addressed the involvement of Keap1, which is a negative regulator of Nrf2 by retrieving it in the cytoplasm. When HepG2 cells were treated with Keap1-specifc siRNA, a significant increase was observed in mRNA levels of ABCC1, ABCC2, and ABCG2 as well as gamma-GCSl, suggesting that induction of ABCC2 and ABCG2 by tBHQ is mediated by the Nrf2/Keap1 system, whereas the induction of ABCC1 may involve a Keap1-dependent but Nrf2-independent mechanism.
引用
收藏
页码:335 / 348
页数:14
相关论文
共 50 条
  • [31] Relationship between expression of ATP-binding cassette (ABC) transporters (ABCB1, ABCC1, ABCG2) and breast cancer subtypes
    Yamada, Akimitsu
    Ishikawa, Takashi
    Kimura, Mariko
    Shimizu, Daisuke
    Tanabe, Mikiko
    Chishima, Takashi
    Kondo, Keiichi
    Sasaki, Takeshi
    Endo, Itaru
    CANCER RESEARCH, 2011, 71
  • [32] Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists
    Silbermann, Katja
    Li, Jiyang
    Namasivayam, Vigneshwaran
    Baltes, Fabian
    Bendas, Gerd
    Stefan, Sven Marcel
    Wiese, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (18) : 10412 - 10432
  • [33] New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition
    van der Schoor, Lori W. E.
    Verkade, Henkjan J.
    Kuipers, Folkert
    Jonker, Johan W.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (02) : 273 - 293
  • [34] High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters
    Ivnitski-Steele, Irena
    Larson, Richard S.
    Lovato, Debbie M.
    Khawaja, Hadya M.
    Winter, Stuart S.
    Oprea, Tudor I.
    Sklar, Larry A.
    Edwards, Bruce S.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (02) : 263 - 276
  • [35] DISTRIBUTION OF ABCG2 (BCRP) AND ABCC2 (MRP2) MRNAS IN RAT SMALL INTESTINE AND LIVER
    Horibe, Sayo
    Takara, Kohji
    Minegaki, Tetsuya
    Ohnishi, Noriaki
    Yokoyama, Teruyoshi
    EXCLI JOURNAL, 2009, 8 : 12 - 19
  • [36] DISTRIBUTION OF ABCG2 (BCRP) AND ABCC2 (MRP2) MRNAS IN RAT SMALL INTESTINE AND LIVER
    Horibe, Sayo
    Takara, Kohji
    Minegaki, Tetsuya
    Ohnishi, Noriaki
    Yokoyama, Teruyoshi
    EXCLI JOURNAL, 2009, 8 : 12 - 19
  • [37] The Prognostic Value of ABCG2 and ABCC1 Expression in Lung Cancer: A Meta-Analysis
    Yu, H.
    Li, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [38] The mycotoxin zearalenone and its metabolites specifically interact with transporter proteins ABCC1, ABCC2, and ABCC3
    Lecoeur, Sylvaine
    Videmann, Bernadette
    Mazallon, Michele
    Delaforge, Marcel
    TOXICOLOGY LETTERS, 2009, 189 : S75 - S75
  • [39] Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium (vol 26, pg 1419, 2012)
    Martino, A.
    Campa, D.
    Buda, G.
    Sainz, J.
    Garcia-Sanz, R.
    Jamroziak, K.
    Reis, R. M.
    Weinhold, N.
    Jurado, M.
    Rios, R.
    Szemraj-Rogucka, Z.
    Marques, H.
    Szemraj, J.
    Stein, A.
    Kumar, R.
    Orciuolo, E.
    Gemignani, F.
    Landi, S.
    Goldschmidt, H.
    Petrini, M.
    Dumontet, C.
    Canzian, F.
    Rossi, A. M.
    LEUKEMIA, 2013, 27 (07) : 1615 - 1616
  • [40] A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis
    Campa, Daniele
    Mueller, Phillip
    Edler, Lutz
    Knoefel, Lena
    Barale, Roberto
    Heussel, Claus P.
    Thomas, Michael
    Canzian, Federico
    Risch, Angela
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (12) : 2920 - 2928